MCRB
Seres Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$8.63
-0.42 ▼ -4.64%
🌙 3월 13일 7:56 PM ET (한국 3/14 08:56)
$8.45
-0.18 ▼ -2.09%
| Index | - | P/E | 10.65 | EPS (ttm) | 0.81 | Insider Own | 25.87% | Shs Outstand | 0.01B | Perf Week | -5.48% |
| Market Cap | 0.08B | Forward P/E | - | EPS next Y | -15.35% | Insider Trans | -0.13% | Shs Float | 0.01B | Perf Month | -38.75% |
| Enterprise Value | 0.12B | PEG | - | EPS next Q | -1.81 | Inst Own | 14.21% | Short Float | 9.76% | Perf Quarter | -49.18% |
| Income | 0.01B | P/S | 104.72 | EPS this Y | -1342.19% | Inst Trans | 3.73% | Short Ratio | 9.19 | Perf Half Y | -50.88% |
| Sales | 0.00B | P/B | 1.87 | EPS next 5Y | - | ROA | 4.1% | Short Interest | 0.66M | Perf YTD | -42% |
| Book/sh | 4.63 | P/C | 1.81 | EPS past 3/5Y | - | ROE | 19.64% | 52W High | -71.21% ($29.98) | Perf Year | -32.41% |
| Cash/sh | 4.77 | P/FCF | 96.2 | Sales past 3/5Y | -51.99% -52.67% | ROIC | 4.88% | 52W Low | 32.16% ($6.53) | Perf 3Y | -91.98% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 104.25% | Gross Margin | -423.83% | Volatility(W/M) | 6.05% 9.65% | Perf 5Y | -97.98% |
| Dividend TTM | - | EV/Sales | 151.81 | Sales Y/Y TTM | 448.44% | Oper. Margin | -11910.14% | ATR (14) | 0.8 | Perf 10Y | -98.29% |
| Dividend Ex-Date | - | Quick Ratio | 2.56 | EPS Q/Q | 11.22% | Profit Margin | 721.93% | RSI (14) | 34.86 | Recom | 2 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.56 | Sales Q/Q | - | SMA20 | -1.94% ($8.8) | Beta | 0.27 | Target Price | $21 |
| Payout | - | Debt/Eq | 1.88 | Earnings | 3000000 | SMA50 | -30.69% ($12.45) | Rel Volume | 0.53 | Prev Close | $9.05 |
| Employees | 66 | LT Debt/Eq | 1.64 | EPS/Sales Surpr. | 15.64% - | SMA200 | -41.05% ($14.64) | Avg Volume(3M) | 0.07M | Price | $8.63 |
| IPO | 2015/6/26 | Option/Short | Yes/Yes | Trades | 478 | Volume | 38,094 | Change | -4.64% |
뉴스 로딩 중...